| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Lithium Technologies | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $451.15M | Series F-3 | 4/16/2015 | $35.2M | $1.06B | $7.04 | Undisclosed Investors | ||||
 | Mandae | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $15.1M | Series B | 5/2/2018 | $7.27M | $33.81M | $0.77 | IFC, UPS Strategic Enterprise Fund, Mercado Libre Fund, Tekton Ventures, FJ Labs, Performa Investimentos, Qualcomm Ventures, Monashees, Icon Holding Company | ||||
 | Mariana Oncology | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $250M | Series B | 9/7/2023 | $175M | $311.65M | $1.06 | Deep Track Capital, Forbion, Atlas Ventures, Access Biotechnology, RA Capital Management, Nextech Invest, Surveyor Capital, Eli Lilly and Company | ||||
 | Matterport | Industrial Augmented / Virtual Reality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $144.15M | Series D | 4/29/2020 | $86.21M | $439.01M | $8.31 | Lux Capital, DCM Ventures, Qualcomm Ventures, Rev1 Ventures, Prairie Management Group, Plug and Play Tech Center, CBRE Group, BoxGroup, iRobot Ventures | ||||
 | Memora Health | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $90.4M | Series A-1 | 4/18/2023 | $30M | $420M | $3.22 | General Catalyst, Northwell Holdings, NorthShore, Edward Elmhurst Health, PagsGroup, Andreessen Horowitz, Transformation Capital, Frist Cressey Ventures | ||||
 | MIRROR | Consumer & Lifestyle Fitness | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Oatly | Foodtech Food Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Obé | Consumer & Lifestyle Fitness | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $20.38M | Series A | 7/22/2021 | $15M | $184.46M | $10.26 | CAVU Venture Partners, Athleta, Samsung Next, Wheelhouse Entertainment, WW International, Cassius Ventures, Ludlow Ventures, Harris Blitzer Sports Entertainment, BDMI | ||||
 | OctoAI | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $265.2M | Series C-2 | 11/1/2021 | $81.3M | $809.18M | $13.97 | Tiger Global Management, Addition, Madrona Venture Group, Amplify Partners | ||||
 | ON24 | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | One Medical Group | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $437.68M | Series I | 8/22/2018 | $250M | $1.5B | $12.43 | The Carlyle Group | ||||
 | Parallel Finance | Fintech Blockchain | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Paxata | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $179.66M | Series C3 | 1/1/2019 | $20M | $205.28M | $2.75 | Synapse Partners | ||||
 | PerimeterX | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $119.16M | Series D | 2/23/2021 | $30.9M | $401.9M | $2.97 | Alliance Bernstein, Stereo Capital, JS Capital, Golden Arc Capital, Adams Street Partners, Canaan Partners, DTCP, Scale Venture Partners, Vertex Ventures | ||||
 | Plastiq | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $407.39M | Series E | 1/31/2022 | $34.7M | $713.51M | $9.75 | Accomplice, Wildcat Capital Management | ||||
 | PlexTrac | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $83.47M | Series B | 2/2/2022 | $60M | $291.38M | $10.15 | Insight Partners, Madrona Venture Group, Noro-Moseley Partners, StageDotO Ventures | ||||
 | PMV Pharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Proteus Digital Health | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $397.36M | Series H | 4/15/2016 | $50M | $1.64B | $15.80 | Undisclosed Investors | ||||
 | Pulley | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $50.25M | Series B | 7/13/2022 | $39.74M | $245.11M | $9.15 | Founders Fund, Stripe, Elad Gil, Jack Altman, Avichal Garg | ||||
 | Recursion Pharmaceuticals | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Revolution Medicines | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Rocket Lab | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $277.55M | Series E-1 | 5/18/2020 | $20.5M | $1.42B | $31.53 | Undisclosed Investors | ||||
 | Sight Sciences | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Sirnaomics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||